Spots Global Cancer Trial Database for khasraw
Every month we try and update this database with for khasraw cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma | NCT03927222 | Glioblastoma | Human CMV pp65-... Temozolomide Tetanus-Diphthe... GM-CSF 111-Indium-labe... | 18 Years - | Duke University | |
Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma | NCT03927222 | Glioblastoma | Human CMV pp65-... Temozolomide Tetanus-Diphthe... GM-CSF 111-Indium-labe... | 18 Years - | Duke University | |
The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation | NCT04937413 | Malignant Gliom... Glioblastoma | Evolocumab | 18 Years - | Duke University | |
ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM | NCT05283109 | Glioma, Maligna... | Tumor Associate... Hiltonol | 18 Years - | Duke University | |
GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM | NCT05695976 | Glioblastoma Glioma, Maligna... | 18 Years - | Duke University |